Urinary proteome in a snapshot: Normal urine and glomerulonephritis

Laura Santucci, Giovanni Candiano, Maurizio Bruschi, Monica Bodria, Corrado Murtas, Andrea Petretto, Gian Marco Ghiggeri

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The analysis of the urinary proteome is a potential source of information regarding the kidney's physiopathology. A clear knowledge of the protein composition of normal urine is an essential prerequisite to looking at its pathology. Technological evolution in the field of proteomics (2-dimensional [2D] electrophoresis, equalization, mass spectrometry and exosomes) has greatly expanded the power of analysis, allowing the detection of almost 2,000 spots in normal urine, only a minor part of which has been characterized as isoforms of known proteins. The identity of most spots (80%) remains to be determined. The analysis of urine composition in nephrotic syndrome (glomerulosclerosis and membranous nephropathy) and in lupus nephritis is in progress, but has not yet furnished any relevant material. The unique exception is the presence of acidic components that suggests alteration of the charge selectivity properties of the glomerular wall in cases of heavy proteinuria. In lupus nephritis, prostaglandin-H2-isomerase and hepcidin have also been identified as activity biomarkers. Several overexpressed or underexpressed proteins have also been found in urine IgA nephropathy, but their specificity needs validation. Decreased levels of aquaporin 2 and of inter-α-trypsin-inhibitor heavy chain 4 have been associated, respectively, with hypertension and with a different response to angiotensin-converting enzyme inhibition in IgA nephropathy patients. From the present stage, mainly characterized by discovery of new proteins in urine, we should now proceed to their validation as biomarkers of diseases and possibly to clinical trials. Participation by basic scientists and clinicians together in projects launched by worldwide organizations is of vital importance.

Original languageEnglish
Pages (from-to)610-616
Number of pages7
JournalJournal of Nephrology
Volume26
Issue number4
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Proteome
Glomerulonephritis
Urine
Lupus Nephritis
Immunoglobulin A
Biomarkers
Aquaporin 2
Prostaglandin H2
Hepcidins
Exosomes
Membranous Glomerulonephritis
Proteins
Trypsin Inhibitors
Nephrotic Syndrome
Peptidyl-Dipeptidase A
Proteinuria
Proteomics
Electrophoresis
Mass Spectrometry
Protein Isoforms

Keywords

  • Glomerulonephritis
  • Normal urine
  • Urinary proteome

ASJC Scopus subject areas

  • Nephrology

Cite this

Urinary proteome in a snapshot : Normal urine and glomerulonephritis. / Santucci, Laura; Candiano, Giovanni; Bruschi, Maurizio; Bodria, Monica; Murtas, Corrado; Petretto, Andrea; Ghiggeri, Gian Marco.

In: Journal of Nephrology, Vol. 26, No. 4, 07.2013, p. 610-616.

Research output: Contribution to journalArticle

Santucci, Laura ; Candiano, Giovanni ; Bruschi, Maurizio ; Bodria, Monica ; Murtas, Corrado ; Petretto, Andrea ; Ghiggeri, Gian Marco. / Urinary proteome in a snapshot : Normal urine and glomerulonephritis. In: Journal of Nephrology. 2013 ; Vol. 26, No. 4. pp. 610-616.
@article{3c08ad323a6d4dde88108e5ff67d787e,
title = "Urinary proteome in a snapshot: Normal urine and glomerulonephritis",
abstract = "The analysis of the urinary proteome is a potential source of information regarding the kidney's physiopathology. A clear knowledge of the protein composition of normal urine is an essential prerequisite to looking at its pathology. Technological evolution in the field of proteomics (2-dimensional [2D] electrophoresis, equalization, mass spectrometry and exosomes) has greatly expanded the power of analysis, allowing the detection of almost 2,000 spots in normal urine, only a minor part of which has been characterized as isoforms of known proteins. The identity of most spots (80{\%}) remains to be determined. The analysis of urine composition in nephrotic syndrome (glomerulosclerosis and membranous nephropathy) and in lupus nephritis is in progress, but has not yet furnished any relevant material. The unique exception is the presence of acidic components that suggests alteration of the charge selectivity properties of the glomerular wall in cases of heavy proteinuria. In lupus nephritis, prostaglandin-H2-isomerase and hepcidin have also been identified as activity biomarkers. Several overexpressed or underexpressed proteins have also been found in urine IgA nephropathy, but their specificity needs validation. Decreased levels of aquaporin 2 and of inter-α-trypsin-inhibitor heavy chain 4 have been associated, respectively, with hypertension and with a different response to angiotensin-converting enzyme inhibition in IgA nephropathy patients. From the present stage, mainly characterized by discovery of new proteins in urine, we should now proceed to their validation as biomarkers of diseases and possibly to clinical trials. Participation by basic scientists and clinicians together in projects launched by worldwide organizations is of vital importance.",
keywords = "Glomerulonephritis, Normal urine, Urinary proteome",
author = "Laura Santucci and Giovanni Candiano and Maurizio Bruschi and Monica Bodria and Corrado Murtas and Andrea Petretto and Ghiggeri, {Gian Marco}",
year = "2013",
month = "7",
doi = "10.5301/jn.5000233",
language = "English",
volume = "26",
pages = "610--616",
journal = "Journal of Nephrology",
issn = "1121-8428",
publisher = "Springer International Publishing",
number = "4",

}

TY - JOUR

T1 - Urinary proteome in a snapshot

T2 - Normal urine and glomerulonephritis

AU - Santucci, Laura

AU - Candiano, Giovanni

AU - Bruschi, Maurizio

AU - Bodria, Monica

AU - Murtas, Corrado

AU - Petretto, Andrea

AU - Ghiggeri, Gian Marco

PY - 2013/7

Y1 - 2013/7

N2 - The analysis of the urinary proteome is a potential source of information regarding the kidney's physiopathology. A clear knowledge of the protein composition of normal urine is an essential prerequisite to looking at its pathology. Technological evolution in the field of proteomics (2-dimensional [2D] electrophoresis, equalization, mass spectrometry and exosomes) has greatly expanded the power of analysis, allowing the detection of almost 2,000 spots in normal urine, only a minor part of which has been characterized as isoforms of known proteins. The identity of most spots (80%) remains to be determined. The analysis of urine composition in nephrotic syndrome (glomerulosclerosis and membranous nephropathy) and in lupus nephritis is in progress, but has not yet furnished any relevant material. The unique exception is the presence of acidic components that suggests alteration of the charge selectivity properties of the glomerular wall in cases of heavy proteinuria. In lupus nephritis, prostaglandin-H2-isomerase and hepcidin have also been identified as activity biomarkers. Several overexpressed or underexpressed proteins have also been found in urine IgA nephropathy, but their specificity needs validation. Decreased levels of aquaporin 2 and of inter-α-trypsin-inhibitor heavy chain 4 have been associated, respectively, with hypertension and with a different response to angiotensin-converting enzyme inhibition in IgA nephropathy patients. From the present stage, mainly characterized by discovery of new proteins in urine, we should now proceed to their validation as biomarkers of diseases and possibly to clinical trials. Participation by basic scientists and clinicians together in projects launched by worldwide organizations is of vital importance.

AB - The analysis of the urinary proteome is a potential source of information regarding the kidney's physiopathology. A clear knowledge of the protein composition of normal urine is an essential prerequisite to looking at its pathology. Technological evolution in the field of proteomics (2-dimensional [2D] electrophoresis, equalization, mass spectrometry and exosomes) has greatly expanded the power of analysis, allowing the detection of almost 2,000 spots in normal urine, only a minor part of which has been characterized as isoforms of known proteins. The identity of most spots (80%) remains to be determined. The analysis of urine composition in nephrotic syndrome (glomerulosclerosis and membranous nephropathy) and in lupus nephritis is in progress, but has not yet furnished any relevant material. The unique exception is the presence of acidic components that suggests alteration of the charge selectivity properties of the glomerular wall in cases of heavy proteinuria. In lupus nephritis, prostaglandin-H2-isomerase and hepcidin have also been identified as activity biomarkers. Several overexpressed or underexpressed proteins have also been found in urine IgA nephropathy, but their specificity needs validation. Decreased levels of aquaporin 2 and of inter-α-trypsin-inhibitor heavy chain 4 have been associated, respectively, with hypertension and with a different response to angiotensin-converting enzyme inhibition in IgA nephropathy patients. From the present stage, mainly characterized by discovery of new proteins in urine, we should now proceed to their validation as biomarkers of diseases and possibly to clinical trials. Participation by basic scientists and clinicians together in projects launched by worldwide organizations is of vital importance.

KW - Glomerulonephritis

KW - Normal urine

KW - Urinary proteome

UR - http://www.scopus.com/inward/record.url?scp=84880082960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880082960&partnerID=8YFLogxK

U2 - 10.5301/jn.5000233

DO - 10.5301/jn.5000233

M3 - Article

C2 - 23065920

AN - SCOPUS:84880082960

VL - 26

SP - 610

EP - 616

JO - Journal of Nephrology

JF - Journal of Nephrology

SN - 1121-8428

IS - 4

ER -